FTC Can't Pause $625M Hydrogen Peroxide Deal
A D.C. federal court has rejected the Federal Trade Commission's bid to pause Evonik's planned $625 million purchase of fellow hydrogen peroxide producer PeroxyChem while an in-house merger challenge plays out....To view the full article, register now.
Already a subscriber? Click here to view full article